Session Details

P002 Annual Business Meeting and Plenary

Sun, Mar 21, 9:00 AM - 12:00 PM
2.5 CME Available Plenary

DESCRIPTION

During the Annual Business Meeting, hear from the AAD/A’s president Murad Alam, MD, MSCI, MBA, FAAD and Secretary-Treasurer Keyvan Nouri, MD, FAAD about the AAD/As state of affairs.

INFORMAL DISCUSSION OF ISSUES OF IMPORTANCE FROM THE FLOOR*
Pursuant to the Administrative Regulation of the American Academy of Dermatology and the American Academy of Dermatology Association, during any debate at a membership meeting each speaker must introduce themselves by name and professional position. He or she must also identify any potential conflicts of interest. *No CME Credit.

The plenary session offers attendees the opportunity to hear from renowned experts on topics that impact dermatologists today. Speakers include Academy leadership and award-winning named lecturers.

LEARNING OBJECTIVES

1.

Discuss remarkable changes in health care concerns and changes in educational delivery tools.

DIRECTOR

Howard Wooding Rogers, MD, PhD, FAAD

Howard Wooding Rogers, MD, PhD, FAAD

SPEAKERS

Nada Elbuluk, MSc, MD, FAAD

Nada Elbuluk, MSc, MD, FAAD

University of Southern California, Keck School of Medicine

William D. James, MD, FAAD

William D. James, MD, FAAD

Department of Dermatology, University of Pennsylvania School of Medicine

Youn H. Kim, MD, FAAD

Youn H. Kim, MD, FAAD

DISCLOSURES

Nada Elbuluk, MSc, MD, FAAD

AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Advisory Board(Fees); L'Oreal USA Inc. – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); SkinCeuticals LLC – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Teva Pharmaceuticals USA – Consultant (1099 relationship)(Fees); The Skin of Color Society – Board of Directors(No Compensation Received); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VisualDx – Consultant(Stock Options);

William D. James, MD, FAAD

Elsevier Inc. – Other(Other Financial Benefit); WebMD – Other(Honoraria);

Youn H. Kim, MD, FAAD

CRISPR Therapeutics – Investigator(Grants/Research Funding); Dren Bio, Inc – Investigator(Grants/Research Funding), Other(No Compensation Received); Innate Pharma S.A. – Other(No Compensation Received); Innate Pharma, S.A. – Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LIBO Pharma Corp. – Advisory Board(Honoraria); ONO-Pharma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Secura Bio – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Speaker(Honoraria); Treeline – Investigator(Grants/Research Funding);

Howard Wooding Rogers, MD, PhD, FAAD

Biofrontera AG – Consultant (1099 relationship)(Fees);